Ticker
VCELCompany Name
VERICEL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 80.53M | 1.96 | $ 41.13M |
3/31/2025 | $ 79.7M | 2.02 | $ 39.45M |
12/31/2024 | $ 85.05M | 1.69 | $ 50.29M |
9/30/2024 | $ 70.35M | 1.7 | $ 41.35M |
6/30/2024 | $ 75.85M | 1.73 | $ 43.86M |
3/31/2024 | $ 70.74M | 1.94 | $ 36.47M |
12/31/2023 | $ 86.87M | 1.9 | $ 45.75M |
9/30/2023 | $ 83.56M | 2.32 | $ 35.95M |
6/30/2023 | $ 70.82M | 1.99 | $ 35.61M |
3/31/2023 | $ 61.83M | 2.15 | $ 28.75M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for VERICEL CORP is calculated as follows: CashnEq [ $ 43.72M ] / LiabilitesC [ $ 21.31M ]
(=) Cash Ratio [ 2.05 ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |